The hidden bioactive molecules: miRNAs loaded in extracellular vesicles might act as bioactive constituents in European mistletoe

隐藏的生物活性分子:细胞外囊泡中装载的 miRNA 可能充当欧洲槲寄生的生物活性成分

基本信息

项目摘要

Herbal products are globally accepted as a valid complementary system of therapy in the form of pharmaceuticals or food supplements. Often their bioactive constituents and corresponding interactions with human have not been comprehensively characterized. Various studies around the world have been initiated to develop scientific evidence-based herbal therapies. New plant bioactive molecules are being discovered. MicroRNAs (miRNAs) are a class of approximately 22 nucleotides single-stranded non-coding RNAs that play crucial roles in gene expression. Recently, the cross-kingdom of plant derived miRNAs has attracted great attraction. For example, the rice miRNAs have been suggested to enter mammalian bloodstream and have a functional role in mammalian metabolism. Plant-derived miR159 can target human genes and suppress breast cancer cell growth in vitro and in vivo. These studies suggested that human genes can be regulated by dietary plant miRNAs, providing thrilling clues that medicinal plants miRNAs might be the hidden bioactive compounds regulating human health and diseases. Mistletoe (Viscum album L.) has been used traditionally in Europe for centuries for the treatment of cancer and cardiovascular diseases but their scientific background is still controversially discussed. By using high-throughput Illumina sequencing and bioinformatics analysis, our previous study indicated that mistletoe miRNAs might be involved in the pharmacological effects of mistletoe. Further experimental validations are currently urgent to confirm the bioactivities of these plant miRNAs. Considering plant miRNAs are not stable in enzymatic environment such as herb extracts and mammalian body fluids, being encapsulated into extracellular vesicles (EVs) that are membrane-enclosed nano-sized particles released by cells, could offer miRNAs nano-shuttles allowing them to travel long distances. Herein, we propose that mistletoe miRNAs might serve as an independent category of active ingredients and might be responsible for or at least contribute to the pharmacological effects (e.g. anti-tumor effect) of mistletoe. Mistletoe EVs might act as effective vehicles to deliver miRNAs with intact functionality, and mediate the cross-kingdom regulation of mistletoe miRNAs. Proposed investigations will be focused on the profiling of cross-kingdom regulatory miRNAs, identification of mammalian targets and visualization of mistletoe EVs mediated miRNA delivery. If our hypothesis is proven, it will promote our understanding of miRNA-based bioactive ingredients in medicinal plants provide scientific support for folk medicinal use and clinical use of medicinal plants. More importantly, it will open new ways for the development of miRNA-based therapies to prevent or treat human diseases.
草药产品是全球公认的有效的补充系统的治疗形式的药品或食品补充剂。通常它们的生物活性成分及其与人体的相互作用尚未得到全面的表征。世界各地已经开展了各种研究,以开发科学证据为基础的草药疗法。新的植物生物活性分子正在被发现。MicroRNAs (miRNAs)是一类约22个核苷酸的单链非编码rna,在基因表达中起着至关重要的作用。近年来,植物源性mirna的跨界研究引起了极大的关注。例如,水稻mirna被认为可以进入哺乳动物的血液,并在哺乳动物的代谢中发挥功能作用。植物源性miR159在体内体外均可靶向人类基因,抑制乳腺癌细胞生长。这些研究表明,人类基因可以通过膳食植物mirna进行调控,这为药用植物mirna可能是调节人类健康和疾病的隐藏生物活性化合物提供了令人兴奋的线索。槲寄生(Viscum album L.)在欧洲被传统地用于治疗癌症和心血管疾病已有几个世纪了,但它们的科学背景仍在争论中。通过高通量Illumina测序和生物信息学分析,我们的前期研究表明槲寄生mirna可能参与了槲寄生的药理作用。目前迫切需要进一步的实验验证来确认这些植物mirna的生物活性。考虑到植物miRNAs在酶促环境(如草药提取物和哺乳动物体液)中不稳定,将其封装到细胞外囊泡(ev)中,即细胞释放的膜封闭纳米级颗粒,可以为miRNAs提供纳米穿梭器,使其能够长距离旅行。在此,我们提出槲寄生mirna可能作为一个独立的活性成分类别,并且可能负责或至少有助于槲寄生的药理作用(例如抗肿瘤作用)。槲寄生ev可能作为递送功能完整的mirna的有效载体,并介导槲寄生mirna的跨界调控。拟议的研究将集中在跨王国调控miRNA的分析,哺乳动物靶点的鉴定和槲寄生ev介导的miRNA传递的可视化。如果我们的假设得到证实,将促进我们对药用植物中基于mirna的生物活性成分的认识,为药用植物的民间用药和临床应用提供科学支持。更重要的是,它将为开发基于mirna的疗法来预防或治疗人类疾病开辟新的途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dr. Wenyan Xie, Ph.D.其他文献

Dr. Wenyan Xie, Ph.D.的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

中药复方“芍药甘草汤”活性成分的单克隆抗体制备及剔除分析法的建立
  • 批准号:
    30572316
  • 批准年份:
    2005
  • 资助金额:
    28.0 万元
  • 项目类别:
    面上项目
新功能肽Aglycin降低高血糖的机理和药理研究
  • 批准号:
    30470823
  • 批准年份:
    2004
  • 资助金额:
    30.0 万元
  • 项目类别:
    面上项目

相似海外基金

Atomic-Scale Engineering of Bioactive Organic Molecules on Surfaces
表面生物活性有机分子的原子尺度工程
  • 批准号:
    DP240100464
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Discovery Projects
Mining the chemodiversity of the genus Myrica to reveal bioactive molecules for their medicinal uses
挖掘杨梅属的化学多样性,揭示其药用生物活性分子
  • 批准号:
    2880591
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Studentship
Unlocking New Chemistries in Extant Enzymes for Synthesizing Bioactive Molecules
解锁现有酶中用于合成生物活性分子的新化学成分
  • 批准号:
    10784165
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Transforming Amines into Complex Polycyclic Molecules and Bioactive Natural Products
将胺转化为复杂的多环分子和生物活性天然产物
  • 批准号:
    2247651
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
REU Site: Synthesis and Characterization of Bioactive Orbioinspired Molecules
REU 网站:生物活性 Orbio 启发分子的合成和表征
  • 批准号:
    2244200
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Modern Synthetic Methods and their Application to the Synthesis of Bioactive Target Molecules
现代合成方法及其在生物活性靶分子合成中的应用
  • 批准号:
    RGPIN-2018-06810
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
Bioactive and bioorthogonal molecules for probing living systems
用于探测生命系统的生物活性和生物正交分子
  • 批准号:
    RGPIN-2022-04234
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
A basic research of developing novel preventions and treatments of Barrett's esophagus using bacteria-derived bioactive molecules
利用细菌衍生的生物活性分子开发新的巴雷特食管预防和治疗方法的基础研究
  • 批准号:
    22K08047
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Catalyst Project: New Hydrazine Reagents for Late-Stage Diversification of Bioactive Molecules
催化剂项目:用于生物活性分子后期多样化的新型肼试剂
  • 批准号:
    2200600
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Copper-Catalyzed Borylation for Late-Stage Functionalization of Complex Bioactive Molecules
铜催化硼化用于复杂生物活性分子的后期功能化
  • 批准号:
    547253-2020
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Postgraduate Scholarships - Doctoral
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了